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Reply
We thank Dr. Breithardt for his comment on our study on cardiac
resynchronization therapy (CRT) in patients with narrow QRS
complexes and coexisting systolic asynchrony by echocardiography
(1). Our report suggested the potential beneficial role of CRT for
heart failure patients with narrow QRS complexes if they exhibited
systolic asynchrony by tissue Doppler imaging. This included the
improvement of exercise capacity, symptoms as well as echocar-
diographic findings of left ventricular (LV) reverse remodeling,
and gain in systolic function. The findings are corroborated by the
study of Bleeker et al. (2) in the same issue of the Journal and in 2
previous reports (2–4). Of note, the lack of control group was
pointed out by Dr. Breithardt. We agree this is a potential
limitation, although the data from the aforementioned studies
support the design of a multicenter, randomized, controlled
clinical trial, as stated in our study. In fact, we also provided
additional information to illustrate the independent benefit of
CRT in the narrow QRS group.
First, the study was designed with a pacing “off ” period. During
such a period, the benefits of pacing on cardiac function and LV
reverse remodeling disappeared gradually. Second, those patients
in the narrow QRS group who had significant systolic asynchrony
responded more than did those with minimal asynchrony. Third,
our study also included a group of wide QRS patients, and the
magnitude of response was similar in both the narrow and wide
QRS groups. Intriguingly, we have shown that for a similar level of
systolic dyssynchrony, the magnitude of reverse remodeling re-
sponse is nearly identical in both groups.
As similar to the wide QRS group, we optimized atrioventric-
ular interval by the Ritter method for patients in the narrow QRS
group. As previously mentioned, we did not find any difference in
the optimized atrioventricular interval between the 2 groups.
However, we ensured patients had successful biventricular capture
by examination of a 12-lead electrocardiogram. Arguably, some
patients might have fusion beats, though pacing by both ventric-
ular leads remains present even in fusion beats; hence, pacing
efficacy should not be affected.
In conclusion, our study does not suggest abandoning the
electrocardiogram as a selection criterion for CRT, but recom-
mended the need for multicenter trials for heart failure patients
with a narrow QRS complex by using echocardiography for
screening of systolic asynchrony. It is hoped that this may extend
the benefit of CRT to more heart failure patients beyond the scope
of using wide QRS complex as a surrogate marker for the presence
of systolic asynchrony.
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Cardiac Imaging in Patients
With Chronic Obstructive
Pulmonary Disease and
Chronic Heart Failure
We read with interest the recent study by Le Jemtel et al. (1) on
the diagnostic and therapeutic challenges in patients with coexis-
tent chronic obstructive pulmonary disease (COPD) and chronic
heart failure (CHF). In the proposed diagnostic algorithm, the
investigators suggested radionuclide ventriculography (RNV) in
patients with technically inadequate echocardiographic study.
Although RNV provides an accurate and reproducible method
of assessing ventricular function (2,3) it involves the use of
radiation and the need for peripheral venous access. In addition,
the myocardium itself is not seen, and the spatial resolution is low.
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Cardiovascular magnetic resonance (CMR) has become the
gold standard for determination of left ventricular (LV) volumes
and LV ejection fraction (LVEF) (4). It compares favorably to
available reference methods and has high intraobserver, interob-
server, and test-retest reproducibility (5,6). Moreover, CMR does
not involve the use of ionizing radiation, and LV evaluation by cine
white blood imaging technique can be done without a peripheral
venous access. Cardiovascular magnetic resonance may also pro-
vide tissue characterization of the diseased myocardium and
prognostic information (7). Furthermore, both right ventricular
(RV) volume and function by CMR have been validated in a large,
multiethnic study (8). This is of particular importance in COPD
patients, because RV hypertrophy determined by CMR may provide
the earliest sign of RV pressure overload in COPD (9).
Presently, CMR is considered by professional societies to be an
appropriate test for evaluation of LV function in heart failure
patients with technically limited echocardiogram images (10).
Therefore, we believe CMR should be part of any algorithm for
evaluation of COPD patients with concurrent CHF.
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Reply
We appreciate the interest of Drs. Ntim and Hundley for our
recent study (1) and agree with their helpful comments. We did
not mention cardiovascular magnetic resonance (CMR) as an
alternative imaging approach in patients with a technically inade-
quate echocardiographic study because CMR is not as readily
available to cardiologists as is radionuclide ventriculography.
When readily available and not contraindicated, CMR can cer-
tainly provide the needed information.
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